Buy & Sell Cytokinetics Inc (CYTK) – Cytokinetics Inc Price Today
Aura AI Summary
Key Stats
- $9.70BMarket Cap
- TechnologySector
- -10.7%3M Drawdown
- $10.18BEnterprise Value
- -Dividend Yield
- 10 daysTypical Hold Time
Cytokinetics Inc (CYTK) is currently valued at a market capitalization of $9.70B, with an enterprise value of $10.18B. Over the past 52 weeks, Cytokinetics Inc has traded between a low of $32.3 and a high of $78.77, highlighting its annual price range. Over the past three months, Cytokinetics Inc has recorded a drawdown of -10.7%, reflecting recent price volatility. On average, investors hold Cytokinetics Inc for approximately 10 days, indicating typical investor behavior on the platform.
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Most Recent News
Nvidia signs deal with SK Hynix but South Korean chip stocks fall sharply amid AI trade slowdown
Nvidia CEO Jensen Huang signed a new partnership agreement with South Korean memory-chip maker SK Hynix. Despite this, shares of SK Hynix and Samsung Electronics dropped over 10% each, reflecting investor concerns amid a cooling AI trade. South Korea...

NVIDIA and SK hynix partner to develop AI memory tech, boosting Korean tech amid chip selloff.
NVIDIA and SK hynix announced a multiyear partnership to co-develop next-generation memory for AI systems, including NVIDIA's Vera Rubin supercomputers and other AI platforms. This deal aims to strengthen Korea's tech sector during a global chip mark...

Hong Kong IPOs lead globally but many stocks fall sharply after debut, raising market concerns.
Hong Kong topped global IPO fundraising in 2024 and early 2025, surpassing New York and Nasdaq. However, about half of the 179 companies listed since January 2025 have seen their stock prices drop over three months, underperforming benchmarks. Stocks...
